IL13 and asthma: MiR-146a and miR-106b, in turn, are upregulated in pediatric asthma patients and lead to increased production of IL-5 and IL-13, which stimulate inflammatory cell recruitment, epithelial cell hyperplasia, smooth muscle hyperplasia, goblet cell metaplasia, and extracellular matrix deposition in the respiratory tract [23].